Assessing depression levels in patients with coronary artery disease
Assessing the Prevalence and Severity of Depression Among Coronary Artery Diseases Patients in Baghdad Using the PHQ-9: A Cross-Sectional Study
This study is trying to see how common depression is in people with coronary artery disease in Baghdad and if certain factors make it worse.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Al-Nahrain University Academic / other |
| Locations | 1 site (Baghdad) |
| Trial ID | NCT06740396 on ClinicalTrials.gov |
What this trial studies
This observational study aims to estimate the prevalence and severity of depression among patients diagnosed with coronary artery disease (CAD) in Baghdad, Iraq. Participants will complete the PHQ-9 questionnaire to assess their depressive symptoms and provide demographic and clinical information to explore potential correlations with depression. The study seeks to identify how common depression is in CAD patients and whether specific factors are associated with higher levels of depression. By understanding these relationships, the study aims to shed light on the impact of depression on CAD outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with coronary artery disease who can complete the PHQ-9 questionnaire.
Not a fit: Patients with severe psychiatric disorders unrelated to depression or those currently hospitalized for acute cardiac events may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recognition and management of depression in CAD patients, potentially enhancing their overall health outcomes.
How similar studies have performed: Other studies have indicated a significant prevalence of depression in CAD patients, suggesting that this approach is supported by existing literature.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with coronary artery disease (confirmed through clinical, imaging, or procedural evidence). * Receiving care at designated hospitals in Baghdad. * Able to understand and complete the PHQ-9 questionnaire independently or with minimal assistance. * Consents to participate in the study. Exclusion Criteria: * Patients with a history of severe psychiatric disorders unrelated to depression (e.g., schizophrenia, bipolar disorder). * Patients with cognitive impairments or neurological conditions affecting their ability to complete the questionnaire. * Those currently hospitalized for acute cardiac events (e.g., myocardial infarction) requiring intensive care. * Individuals unwilling to provide informed consent.
Where this trial is running
Baghdad
- College of Medicine - Al-Nahrain University — Baghdad, Iraq (Recruiting)
Study contacts
- Study coordinator: Abdul-Ilah R. Khamis
- Email: allaabed987@ced.nahrainuniv.edu.iq
- Phone: +9647838571013
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.